Global Rituxan Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rituxan Market Insights, Forecast to 2034
RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy.
Global Rituxan market is expected to reach to US$ 914 million in 2024, with a positive growth of %, compared with US$ 1023 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rituxan industry is evaluated to reach US$ 469.8 million in 2029. The CAGR will be -10.5% during 2024 to 2029.
Rituxan, a monoclonal antibody used for the treatment of various cancers and autoimmune disorders, continues to witness strong demand. Factors such as increasing prevalence of target diseases, growing adoption of targeted therapies, and favorable reimbursement policies contribute to market growth. Key players in the market are investing in research and development to expand the indications of Rituxan and develop biosimilar versions. Additionally, strategic collaborations and partnerships are facilitating market expansion. However, challenges such as the availability of alternative therapies and the high cost of treatment may limit market growth. Overall, the Rituxan market is expected to exhibit positive growth in the coming years.
Report Covers
This report presents an overview of global Rituxan market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rituxan market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg
Intravenous Use
Subcutaneous Use
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rituxan plant distribution, commercial date of Rituxan, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rituxan introduction, etc. Rituxan Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rituxan
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Rituxan market is expected to reach to US$ 914 million in 2024, with a positive growth of %, compared with US$ 1023 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rituxan industry is evaluated to reach US$ 469.8 million in 2029. The CAGR will be -10.5% during 2024 to 2029.
Rituxan, a monoclonal antibody used for the treatment of various cancers and autoimmune disorders, continues to witness strong demand. Factors such as increasing prevalence of target diseases, growing adoption of targeted therapies, and favorable reimbursement policies contribute to market growth. Key players in the market are investing in research and development to expand the indications of Rituxan and develop biosimilar versions. Additionally, strategic collaborations and partnerships are facilitating market expansion. However, challenges such as the availability of alternative therapies and the high cost of treatment may limit market growth. Overall, the Rituxan market is expected to exhibit positive growth in the coming years.
Report Covers
This report presents an overview of global Rituxan market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rituxan market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg
Segment by Application
Intravenous Use
Subcutaneous Use
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rituxan plant distribution, commercial date of Rituxan, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rituxan introduction, etc. Rituxan Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Rituxan
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports